Sarcoidosis: From Diagnosis to Management

Dear Colleagues,

Sarcoidosis presents a number of challenges for both diagnosis and management, making it a complex and frustrating condition for both patients and healthcare professionals.

With respect to diagnosis, (1) patients present with non-specific symptoms that can mimic other diseases, (2) there are no definitive tests for diagnosis, so it requires a multidisciplinary approach examining the presentation, imaging, and biopsies, (3) the disease can affect multiple organs, leading to diverse presentations, and (4) it is imperative to rule out other conditions with similar symptoms, including TB and lymphoma.

With respect to prognosis, this can vary widely depending on the extent and severity of organ involvement. In many cases, sarcoidosis resolves spontaneously or with minimal treatment. However, in some individuals, the disease can be chronic and lead to long-term complications, such as pulmonary fibrosis or organ dysfunction. The prognostic factors include the extent of organ involvement, the presence of symptoms, and the response to treatment.

Finally, sarcoidosis is a rare disease with a lack of public awareness that can delay early diagnosis, and there can be challenges in finding specialized healthcare providers who advocate for multi-disciplinary management. The smaller pool of patients makes it less attractive for pharmaceutical companies when it comes to investing in clinical trials. Compounded by multisystem involvement and diverse symptoms, these factors present challenges in accurately measuring the effectiveness of new treatments across the spectrum of the disease.

Despite the challenges, there are still positive developments in the field of sarcoidosis, aiming to improve diagnosis, develop more effective treatments, and understand the cause of the disease. We welcome you to submit your research work related to enhancing the precision of sarcoidosis diagnosis and prognosis and predicting target organ involvement.

Dr. Huzaifa I. Adamali
Guest Editor

Letter from Sarcoidosis UK: Sarcoidosis affects everyone differently, which can make both diagnosis and management difficult. Due to the complicated and varied nature of sarcoidosis, many patients wait a long time to be diagnosed and are often misdiagnosed. Once diagnosed, patients face the difficult news that there is no known cure, and effective treatment can be complicated and potentially toxic. Any research into sarcoidosis could be life-changing for patients, whether examining our understanding of the disease or developing more effective treatments or diagnostic tools. We have been pleased to see the recent increased interest in sarcoidosis-specific research and clinical trials. We welcome submissions from various fields in the hope that this Special Issue can inspire further research and development to help improve outcomes for patients.

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• sarcoidosis
• granulomas
• interstitial lung disease
• lung
• heart
• skin
• liver
• neurological
• joints
• diagnosis imaging
• PET/CT
• chest X-ray